Survodutide — Dual GLP-1 / Glucagon Receptor Agonist (Metabolic Research Peptide)
Survodutide is a next-generation dual agonist peptide that activates both GLP-1 and Glucagon receptors, representing a new class of compounds in metabolic research.
By combining appetite suppression with enhanced energy expenditure, Survodutide is being studied for its potential to support fat reduction, glycemic control, and metabolic flexibility.
Scientific Overview
Developed as a co-agonist targeting both GLP-1R and GCGR, Survodutide mimics the natural incretin hormones responsible for regulating appetite and energy balance.
Research suggests dual activation promotes synergistic effects — combining the satiety and insulin-sensitivity benefits of GLP-1 with the thermogenic and lipolytic effects of glucagon.
This dual mechanism distinguishes Survodutide from single-pathway GLP-1 analogs like Semaglutide or Tirzepatide.
- Promotes fat oxidation and metabolic thermogenesis
- ️ Reduces appetite and food intake
- Preserves lean body mass during caloric deficit
- Improves insulin sensitivity and glucose tolerance
- Supports neuroendocrine balance and metabolic wellness
Product Specifications
| Compound | Survodutide |
| Class | Dual GLP-1 / Glucagon receptor agonist |
| Form | Sterile lyophilized peptide powder |
| Purity | ≥ 98 % (HPLC) |
| CAS | 2381089-83-2 |
| Appearance | White/off-white crystalline |
⚗️ Mechanism of Action
Survodutide acts through dual incretin receptor engagement:
- GLP-1 receptor activation — slows gastric emptying, reduces appetite, and enhances pancreatic insulin release.
- Glucagon receptor activation — increases hepatic lipid oxidation, raises energy expenditure, and mobilizes fat stores.
This dual signaling model encourages rapid visceral fat loss while maintaining balanced glucose levels and metabolic stability.
Research suggests Survodutide may achieve superior body-composition outcomes compared to traditional GLP-1 analogs alone.
Reconstitution & Storage
- Reconstitution: Add Bacteriostatic Water (recommended 1–2 mL per vial).
Alternatives: Sterile Water for short-term use (≤ 3 days) or 0.6 % Acetic Acid for extended preservation. - ❄️ Storage: Keep lyophilized peptide refrigerated (2–8 °C) and protected from light.
After reconstitution, store under the same conditions and use within 20 days.
Research Applications
- Dual incretin receptor pharmacology studies
- Obesity and metabolic-syndrome research
- Body-composition and fat-oxidation modeling
- Insulin sensitivity and glycemic-control assays
- Energy balance and appetite regulation studies
Synergistic Research Pairings
- Tirzepatide — dual GIP/GLP-1 comparison model
- AOD-9604 — targeted lipolysis synergy
- ⚙️ Tesamorelin — visceral fat reduction co-modality
- CJC-1295 / Ipamorelin — GH-axis enhancement for metabolic recovery
⚠️ Disclaimer
For Research Use Only.
Not for human consumption, therapeutic, or diagnostic use.
All data and information are provided for scientific and educational purposes only.
Researchers must be 18 years or older.
This compound is manufactured and handled under sterile research-grade conditions.
Use of this material signifies compliance with all applicable research and safety regulations.
